Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 08, 2018 10:42 ET | Source: InflaRx N.V.

InflaRx N.V. Announces Closing of Primary and Secondary Offering of Common Shares

JENA, Germany, May 08, 2018 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq:IFRX), a biopharmaceutical company developing innovative therapeutics to treat inflammatory diseases by targeting the complement...
May 03, 2018 20:28 ET | Source: InflaRx N.V.

InflaRx N.V. Announces Pricing of Primary and Secondary Offering of Common Shares

JENA, Germany, May 03, 2018 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq:IFRX), a biopharmaceutical company developing innovative therapeutics to treat inflammatory diseases by targeting the complement...
May 02, 2018 07:44 ET | Source: InflaRx N.V.

InflaRx N.V. Announces Proposed Primary and Secondary Offerings of Common Shares

JENA, Germany, May 02, 2018 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq:IFRX), a biopharmaceutical company developing innovative therapeutics to treat inflammatory diseases by targeting the complement...
March 29, 2018 07:00 ET | Source: InflaRx N.V.

InflaRx Full Year 2017 Financial & Operating Results

IFX-1 Positive Phase IIa data in Hidradenitis Suppurativa (HS) patients US$136 million Series D & Nasdaq IPO financings U.S. IND opened, international Phase IIb initiated for IFX-1 in HS...